Private equity major Welsh, Carson, Anderson & Stowe has agreed to commit up to $250m to a strategic partnership with newly-formed Kiniciti, to invest in non-therapeutic companies supporting cell and gene therapy innovation.
Buyout
cell
deal
Deal News
gene
invest
investment
Kiniciti
private equity
Software and Hi-Tech
United States
WCAS
Welsh Carson Anderson & Stowe
Welsh Carson commits up to $250m to newly-formed cell, gene science investor Kiniciti
Most Popular
